Gene · 9261
NIH grants2,214
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 2,214
Download this page as JSON| Grant | Title | MAPKAPK2 papers | Newest fiscal year |
|---|---|---|---|
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 1 | 2025 |
| R01AG044034 | Oxidative Stress and the Development of Osteoarthritis | 1 | 2025 |
| R01AG063913 | Big data and small molecules for Alzheimer's disease | 1 | 2025 |
| R01AG071496 | Systematic modeling and prediction of cell-type-specific and spatiotemporal crosstalk pathways in Alzheimer's Disease | 1 | 2025 |
| R01AG076448 | TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease | 1 | 2025 |
| R01AG082093 | Non-coding RNAs in resilience to Alzheimer’s Disease | 1 | 2025 |
| R01AG082328 | Studying the pathogenic roles of human CD8+ T cells in Alzheimer's disease using a 3D human Peripheral immune Chip. | 1 | 2025 |
| R01AI116323 | Molecular basis of intestinal cryptosporidiosis | 1 | 2025 |
| R01AI118861 | Innate immune-mediated control of pulmonary Legionella pneumophila infection | 1 | 2025 |
| R01AI124690 | Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity | 1 | 2025 |
| R01AI127372 | Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies | 1 | 2025 |
| R01AI127387 | Regulation of Innate Dendritic Cell CTLA-4 | 1 | 2025 |
| R01AI136831 | Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection | 1 | 2025 |
| R01AI165147 | Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1 | 1 | 2025 |
| R01AI165947 | Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike | 1 | 2025 |
| R01AI167732 | Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model | 1 | 2025 |
| R01AI170596 | Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2 | 1 | 2025 |
| R01AI171980 | Function of T cells at the Maternal-Fetal Interface | 1 | 2025 |
| R01AI176601 | Enhancing Susceptibility of HIV Reservoirs to CTL Through a Discovery to Translational Approach | 1 | 2025 |
| R01AR049446 | Mechanisms Regulating Muscle Stem Cell Homeostasis | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/grants?page=9